Notice ID: c4652c8405904bb0acc36fff72c88569Special Notice
6505--Intent to Sole Source - Amyloid Florbetaben Injections
Archived on November 5, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−04:00
- Posted
- August 30, 2024
- Notice type
- Special Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 248-NETWORK CONTRACT OFFICE 8 (36C248)
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24824Q1585
- Notice ID
- c4652c8405904bb0acc36fff72c88569
Description
Page 2 of 2 This is not a solicitation for quotes. This is a Special Notice. The purpose of this Special Notice is to provide notification of the Department of Veterans Affairs (VA) intent of contract action to make a sole source award in accordance with FAR Part 6.302-1. Special Notice of Contract Action: Network Contracting Office (NCO) 8 intends to issue a sole source, firm fixed price contract with a base year and four option years, using other than full and open competition, to SOFIE, Co. for the purchase of FDA approved Neuraceq Florbetaben F-18 Injections for the VA Healthcare Center Miami. Estimated value of this acquisition is approximately $110,000.00/year and $550,000/including base and option years. The estimated award date is on or before October 01, 2024. Qualified sources may submit a quote (or capabilities statement) which shall be considered but shall in no way bind the agency. Reimbursement will not be made for any costs associated with providing or requesting information in response to this Special Notice. Responses shall be submitted via email to Melissa.Everett@va.gov and received no later than 5:00 PM on Friday, September 6, 2024.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24824Q1585- Special NoticeCurrentAug 30, 2024
6505--Intent to Sole Source - Amyloid Florbetaben Injections
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
| - | Awarded | Open | |
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO PETNET SOLUTIONS, INC., located at 810 Innovation Dr. Knoxville, TN 37932 for F18 Florbetapir for the Orlando Healthcare System, 13800 Veterans Way, Orlando, FL 32827. This procurement is being conducted in accordance with 41 USC 3304(a)(1) as implemented by FAR 6.302-1. The North American Industry Classification System code for this procurement is 325412 and the small business administrative size standard is 1,300 Employees. The current Federal Acquisition Circular and the Revolutionary Federal Acquisition Regulation Overhaul dated 07/01/2026. If vendors believe they have the technical capability to meet this specific need, submit a complete technical package, which provides clear and convincing evidence that they can meet the Government s requirement. Submit your response to this notice no later than 09/29/2026, 1:00 PM Eastern Standard Time to Contracting Officer, Benjamin Amato, benjamin.amato@va.gov. Any responses received will be considered for the purposes of validating the requirement as sole source. The Government will not pay for information submitted. This will be the only notice of the Government s intent to solicit, and award to one source to satisfy this requirement. | - | Special Notice | 09/29/2026 |
| - | Awarded | Open | |
Page 2 of 2 Page 2 of 2 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79727R0004 for an unrestricted procurement for Pantoprazole NA Tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation # 36E79727R0004 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 12/22/2026 with a tentative closing date of 01/05/2027. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov. The estimated annual requirements are as follows: Description Size Estimated Annual Requirements PANTOPRAZOLE NA 20MG TAB 90/BT 244,641 PANTOPRAZOLE NA 20MG TAB 500/BT 28,376 OR PANTOPRAZOLE NA 20MG TAB 1000/BT 14,188 PANTOPRAZOLE NA 40MG TAB 90/BT 965,273 PANTOPRAZOLE NA 40MG TAB 500/BT 237,162 OR PANTOPRAZOLE NA 40MG TAB 1000/BT 118,581 | - | Pre-Solicitation | 12/31/2026 |
Emergency Pharmacy Order of DigiFAB | - | Sole Source / J&A | Open |
Additional Details
Solicitation Number
36C24824Q1585
Archive Date
Nov 5, 2024
Office Address
TAMPA, FL, 33637